{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:48:38Z","timestamp":1792100918973,"version":"4.4.0"},"publisher-location":"Boston","reference-count":2,"publisher":"Kluwer Academic Publishers","isbn-type":[{"value":"0306477572","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-306-48382-3_104","type":"book-chapter","created":{"date-parts":[[2006,2,18]],"date-time":"2006-02-18T20:57:40Z","timestamp":1140296260000},"page":"521-523","source":"Crossref","is-referenced-by-count":28,"title":["Human Recombinant Interferon-\u03b12a (rhIFN\u03b12a) for the Treatment of Beh\u00e7et\u2019s Disease with Sight-Threatening Retinal Vasculitis"],"prefix":"10.1007","author":[{"given":"Ina","family":"K\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Zierhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Vonthein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"G\u00dcnaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Hartmut","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"St\u00f6biger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"104_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","volume":"134","author":"Ch.C. Zouboulis","year":"1998","unstructured":"Zouboulis, Ch.C., and Orfanos, C.E., 1998, Treatment of Adamantiades-Beh\u00e7et disease with systemic interferon alfa. Arch. Dermatol. 134: 1010\u20131016.","journal-title":"Arch. Dermatol."},{"key":"104_CR2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.82.5.488","volume":"82","author":"I. K\u00f6tter","year":"1998","unstructured":"K\u00f6tter, I., Eckstein, A.K., St\u00dcbiger, N., et al., 1998, Treatment of ocular symptoms of Beh\u00e7et\u2019s disease with interferon \u03b12a-a pilot study. Br. J. Ophthalmol. 82: 488\u2013494.","journal-title":"Br. J. Ophthalmol."}],"container-title":["Advances in Experimental Medicine and Biology","Adamantiades-Beh\u00e7et\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-306-48382-3_104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T04:30:29Z","timestamp":1619497829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-306-48382-3_104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["0306477572"],"references-count":2,"URL":"https:\/\/doi.org\/10.1007\/0-306-48382-3_104","relation":{},"subject":[]}}